VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2020 | ASH 2020: myeloma transplantation highlights

Jeffrey Matous, MD, Colorado Blood Cancer Institute, Denver, CO, highlights the exciting updates in transplantation data in multiple myeloma presented at ASH 2020. He focuses on the findings of the FORTE (NCT02203643), IFM 2009 (NCT03679351) and EMN02 (NCT01208766) trials, which all take different approaches to improve the overall quality of life, as well as response and survival rates in myeloma patients. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter